Sakura Sakajiri

938 total citations
32 papers, 704 citations indexed

About

Sakura Sakajiri is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Sakura Sakajiri has authored 32 papers receiving a total of 704 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pathology and Forensic Medicine, 13 papers in Oncology and 10 papers in Genetics. Recurrent topics in Sakura Sakajiri's work include Lymphoma Diagnosis and Treatment (16 papers), Viral-associated cancers and disorders (7 papers) and Chronic Lymphocytic Leukemia Research (6 papers). Sakura Sakajiri is often cited by papers focused on Lymphoma Diagnosis and Treatment (16 papers), Viral-associated cancers and disorders (7 papers) and Chronic Lymphocytic Leukemia Research (6 papers). Sakura Sakajiri collaborates with scholars based in Japan, United States and Taiwan. Sakura Sakajiri's co-authors include Norihiko Kawamata, H. Phillip Koeffler, Jonathan Said, Kazuo Oshimi, Takayuki Saitoh, T. Kumagai, Kiyohiko Hatake, Carl W. Miller, Keiji Sugimoto and Shunji Takahashi and has published in prestigious journals such as Blood, Oncogene and Clinical Cancer Research.

In The Last Decade

Sakura Sakajiri

29 papers receiving 694 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sakura Sakajiri Japan 14 358 272 194 110 106 32 704
A Rosolen Italy 19 366 1.0× 263 1.0× 317 1.6× 252 2.3× 87 0.8× 45 956
Claudiu Cotta United States 16 294 0.8× 133 0.5× 123 0.6× 126 1.1× 123 1.2× 50 638
Sanjiv Modi United States 8 245 0.7× 210 0.8× 161 0.8× 81 0.7× 183 1.7× 11 589
Florence Armstrong France 10 290 0.8× 171 0.6× 129 0.7× 118 1.1× 82 0.8× 12 630
Takashi Akasaka Japan 15 222 0.6× 194 0.7× 323 1.7× 120 1.1× 229 2.2× 45 660
Markus Möbs Germany 19 237 0.7× 303 1.1× 250 1.3× 240 2.2× 75 0.7× 42 802
Susanna Mannisto Finland 13 299 0.8× 128 0.5× 126 0.6× 135 1.2× 50 0.5× 26 661
María Rodríguez‐Pinilla Spain 15 317 0.9× 247 0.9× 162 0.8× 42 0.4× 82 0.8× 27 611
J.P. Magaud France 14 430 1.2× 295 1.1× 379 2.0× 169 1.5× 203 1.9× 21 988
Tomohiro Aoki Japan 16 177 0.5× 304 1.1× 257 1.3× 184 1.7× 102 1.0× 45 686

Countries citing papers authored by Sakura Sakajiri

Since Specialization
Citations

This map shows the geographic impact of Sakura Sakajiri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sakura Sakajiri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sakura Sakajiri more than expected).

Fields of papers citing papers by Sakura Sakajiri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sakura Sakajiri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sakura Sakajiri. The network helps show where Sakura Sakajiri may publish in the future.

Co-authorship network of co-authors of Sakura Sakajiri

This figure shows the co-authorship network connecting the top 25 collaborators of Sakura Sakajiri. A scholar is included among the top collaborators of Sakura Sakajiri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sakura Sakajiri. Sakura Sakajiri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Takahashi, Shunji, Yutaka Fujiwara, Kenji Nakano, et al.. (2021). Safety and pharmacokinetics of milademetan, a MDM2 inhibitor, in Japanese patients with solid tumors: A phase I study. Cancer Science. 112(6). 2361–2370. 43 indexed citations
2.
Takahashi, Takeshi, Kensuke Usuki, Kosei Matsue, et al.. (2019). Efficacy and safety of quizartinib in Japanese patients with FLT3-ITD positive relapsed or refractory acute myeloid leukemia in an open-label, phase 2 study. International Journal of Hematology. 110(6). 665–674. 14 indexed citations
3.
Usuki, Kensuke, Hiroshi Handa, Ilseung Choi, et al.. (2019). Safety and pharmacokinetics of quizartinib in Japanese patients with relapsed or refractory acute myeloid leukemia in a phase 1 study. International Journal of Hematology. 110(6). 654–664. 17 indexed citations
4.
Sekiguchi, Yasunobu, Sakura Sakajiri, Keiji Sugimoto, et al.. (2019). Clinical Evaluation of the Efficacy and Safety of Anagrelide Used with or without Hydroxycarbamide in Japanese Patients with Essential Thrombocythemia-A Retrospective Single-Center Study of 35 Cases.. PubMed. 46(7). 1141–1150. 2 indexed citations
5.
Suzuki, Kazuhito, Yasuhito Terui, Noriko Nishimura, et al.. (2014). Rapid Progression of Anemia Related to Tumor-lysis Syndrome Associated with Bortezomib Treatment in Myeloma Patients. Japanese Journal of Clinical Oncology. 44(5). 435–441. 6 indexed citations
6.
7.
Nakano, Kenji, Takeshi Yuasa, Nao Nishimura, et al.. (2012). Feasibility and Efficacy of Combined Cisplatin and Irinotecan Chemotherapy for Poorly Differentiated Neuroendocrine Carcinomas. Japanese Journal of Clinical Oncology. 42(8). 697–703. 34 indexed citations
8.
Ueda, Kyoko, Yasuhito Terui, Masahiro Yokoyama, et al.. (2012). Non-gastric advanced mucosa-associated lymphoid tissue (MALT) lymphoma has worse prognosis than gastric MALT lymphoma even when treated with rituximab-containing chemotherapy. Leukemia & lymphoma. 54(9). 1928–1933. 10 indexed citations
9.
Suzuki, Keigo, Y. Terui, Noriko Nishimura, et al.. (2012). Prognostic Value of C-reactive Protein, Lactase Dehydrogenase and Anemia in Recurrent or Refractory Aggressive Lymphoma. Japanese Journal of Clinical Oncology. 43(1). 37–44. 11 indexed citations
10.
Mishima, Yuko, Yasuhito Terui, Masahiro Yokoyama, et al.. (2012). R-CHOP with dose-attenuated radiation therapy could induce good prognosis in gastric diffuse large B cell lymphoma. Experimental Hematology and Oncology. 1(1). 30–30. 8 indexed citations
11.
Suzuki, Kazuhito, Yasuhito Terui, Kenji Nakano, et al.. (2011). High thymidine kinase activity is a strong predictive factor for poor prognosis in peripheral T-cell lymphoma treated with cyclophosphamide, adriamycin, vincristine and prednisone. Leukemia & lymphoma. 53(5). 849–854. 2 indexed citations
12.
Mishima, Yuko, Yasuhito Terui, Masahiro Yokoyama, et al.. (2010). RCHOP Therapy Overcome Gastric Diffuse Large B Cell Lymphoma without Surgery. Blood. 116(21). 1760–1760. 1 indexed citations
13.
Terui, Yasuhito, Yuji Mishima, Natsuhiko Sugimura, et al.. (2009). Identification of CD20 C-Terminal Deletion Mutations Associated with Loss of CD20 Expression in Non-Hodgkin's Lymphoma. Clinical Cancer Research. 15(7). 2523–2530. 53 indexed citations
14.
Ennishi, Daisuke, Masaru Yokoyama, Y. Terui, et al.. (2008). Soluble interleukin-2 receptor retains prognostic value in patients with diffuse large B-cell lymphoma receiving rituximab plus CHOP (RCHOP) therapy. Annals of Oncology. 20(3). 526–533. 46 indexed citations
15.
Yin, Dong, Dong Xie, Sakura Sakajiri, et al.. (2005). DLK1: increased expression in gliomas and associated with oncogenic activities. Oncogene. 25(13). 1852–1861. 71 indexed citations
16.
Sakajiri, Sakura, T. Kumagai, Norihiko Kawamata, et al.. (2005). Histone deacetylase inhibitors profoundly decrease proliferation of human lymphoid cancer cell lines. Experimental Hematology. 33(1). 53–61. 124 indexed citations
17.
Kawamata, Norihiko, et al.. (2005). Methylation status analysis of cell cycle regulatory genes (p16INK4A, p15INK4B, p21Waf1/Cip1, p27Kip1 and p73) in natural killer cell disorders. European Journal Of Haematology. 74(5). 424–429. 26 indexed citations
18.
Sugimoto, Keiji, Norihiko Kawamata, Sakura Sakajiri, & Kazuo Oshimi. (2002). Molecular Analysis of Oncogenes, ras Family Genes (N‐ras, K‐ras, H‐ras), myc Family Genes (c‐myc, N‐myc) and mdm2 in Natural Killer Cell Neoplasms. Japanese Journal of Cancer Research. 93(11). 1270–1277. 10 indexed citations
19.
Sakajiri, Sakura, Norihiko Kawamata, Motoki Egashira, Kiyoshi Mori, & Kazuo Oshimi. (2001). Molecular Analysis of Tumor Suppressor Genes, Rb, p53,pl6INK4A, pl5INK4B and p14ARF in Natural Killer Cell Neoplasms. Japanese Journal of Cancer Research. 92(10). 1048–1056. 23 indexed citations
20.
Sakajiri, Sakura, et al.. (2000). [Autoimmune myelodysplasias].. PubMed. 155–6. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A Rosolen Breakdown of academic impact, for papers by Claudiu Cotta Breakdown of academic impact, for papers by Sanjiv Modi Breakdown of academic impact, for papers by Florence Armstrong Breakdown of academic impact, for papers by Takashi Akasaka Breakdown of academic impact, for papers by Markus Möbs Breakdown of academic impact, for papers by Susanna Mannisto Breakdown of academic impact, for papers by María Rodríguez‐Pinilla Breakdown of academic impact, for papers by J.P. Magaud Breakdown of academic impact, for papers by Tomohiro Aoki
Rankless by CCL
2026